Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 9 of 9 entries
View as:

Pharmacokinetic Study of Testosterone Enanthate

Phase: N/A Priority: Normal
NCT ID: NCT01887418 Org: User:
Start: 09/30/13 End: 01/31/14 Due: 01/31/15

Actual Human Use of Methotrexate (MTX) Subcutaneously Administered Via the VIBEX™ MTX Auto-Injector Device

Phase: N/A Priority: Normal
NCT ID: NCT01618955 Org: User:
Start: 05/31/12 End: 07/31/12 Due: 07/31/13

Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism

Phase: N/A Priority: Normal
NCT ID: NCT02159469 Org: User:
Start: 07/31/14 End: 11/30/15 Due: 11/30/16

Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism

Phase: N/A Priority: Normal
NCT ID: NCT02777242 Org: User:
Start: 06/30/16 End: 08/31/16 Due: 08/31/17

Exposure Study Comparing 3 Routes of Methotrexate (MTX) Administration

Phase: N/A Priority: Normal
NCT ID: NCT01737944 Org: User:
Start: 01/31/11 End: 06/30/11 Due: 06/30/12

Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism

Phase: N/A Priority: Normal
NCT ID: NCT02504541 Org: User:
Start: 07/31/15 End: 06/30/16 Due: 06/30/17

Study of Topically Administered Oxybutynin Gel in Patients With Urge Incontinence

Phase: N/A Priority: Normal
NCT ID: NCT00909181 Org: User:
Start: 03/31/09 End: 11/30/10 Due: 11/30/11

Pharmacokinetic Study of Subcutaneous Testosterone Enanthate

Phase: N/A Priority: Normal
NCT ID: NCT02233751 Org: User:
Start: 09/30/14 End: 10/31/14 Due: 10/31/15

Comparison of Methotrexate (MTX) and the VIBEX™ MTX Device

Phase: N/A Priority: Normal
NCT ID: NCT01618968 Org: User:
Start: 05/31/12 End: 08/31/12 Due: 08/31/13